blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3268035

EP3268035 - COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE" -DEPENDENT SIGNALLING [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.12.2021
Database last updated on 28.09.2024
FormerGrant of patent is intended
Status updated on  21.03.2021
FormerExamination is in progress
Status updated on  05.02.2021
FormerGrant of patent is intended
Status updated on  29.06.2020
FormerExamination is in progress
Status updated on  17.05.2019
FormerRequest for examination was made
Status updated on  15.12.2017
FormerThe international publication has been made
Status updated on  22.08.2017
Most recent event   Tooltip10.12.2021Application deemed to be withdrawnpublished on 12.01.2022  [2022/02]
Applicant(s)For all designated states
Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley, CA 94710 / US
[2018/14]
Former [2018/03]For all designated states
Aduro BioTech, Inc.
740 Heinz Avenue
Berkeley, California 94710 / US
Inventor(s)01 / KATIBAH, George Edwin
34812 Candice Court
Fremont, CA 94555 / US
02 / KANNE, David
5 Flying Cloud Course
Corte Madera, CA 94925 / US
03 / SUNG, Leonard
25 Rolling Hills Avenue
San Mateo, CA 94403 / US
04 / GAUTHIER, Kelsey
1531 Lafayette St 2
Alameda, CA 94501 / US
05 / GLICKMAN, Laura Hix
36 Rydal Ct.
Oakland, CA 94611 / US
06 / LEONG, Justin
35128 Garcia St.
Union City, CA 94587 / US
07 / MCWHIRTER, Sarah, M.
1010 Peralta Ave.
Albany, CA 94706 / US
08 / DUBENSKY, Jr., Thomas, W.
25 Tanglewood Road
Berkeley, CA 94705 / US
 [2018/03]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2018/03]Wills, Andrew Jonathan, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date16762447.709.03.2016
[2018/03]
WO2016US21597
Priority number, dateUS201562131235P10.03.2015         Original published format: US 201562131235 P
[2018/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016145102
Date:15.09.2016
Language:EN
[2016/37]
Type: A1 Application with search report 
No.:EP3268035
Date:17.01.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.2016 takes the place of the publication of the European patent application.
[2018/03]
Search report(s)International search report - published on:US15.09.2016
(Supplementary) European search report - dispatched on:EP27.09.2018
ClassificationIPC:C07H21/02, C07H19/213, C07H21/00, A61P37/06, A61P29/00, A61P35/00, A61P11/06, A61P3/10, A61K31/7084
[2018/44]
CPC:
A61K31/7084 (EP,EA,US); C07H21/00 (EP,EA,KR,US); A61K39/12 (KR);
A61K39/39 (EA,KR,US); A61P11/06 (EP,EA,US); A61P29/00 (EP,EA,US);
A61P3/10 (EP,EA,US); A61P35/00 (EP,EA,US); A61P37/06 (EP,EA,US);
C07H19/213 (EP,EA,US); C07H21/02 (EP,EA,KR,US); Y02A50/30 (EP,EA,US) (-)
Former IPC [2018/03]A61K39/12, A61K39/39, C07H21/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/03]
Extension statesBA14.09.2017
ME14.09.2017
Validation statesMA31.08.2017
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR AKTIVIERUNG EINER VOM STIMULATOR DES INTERFERON-GENS ABHÄNGIGEN SIGNALISIERUNG[2018/03]
English:COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE" -DEPENDENT SIGNALLING[2018/03]
French:COMPOSITIONS ET PROCÉDÉS D'ACTIVATION DE LA SIGNALISATION DÉPENDANTE DE « STIMULATEUR DE GÈNES D'INTERFÉRON »[2018/03]
Entry into regional phase31.08.2017National basic fee paid 
31.08.2017Search fee paid 
31.08.2017Designation fee(s) paid 
31.08.2017Examination fee paid 
Examination procedure21.08.2017Date on which the examining division has become responsible
31.08.2017Examination requested  [2018/03]
24.09.2018Observations by third parties
05.10.2018Observations by third parties
24.04.2019Amendment by applicant (claims and/or description)
21.05.2019Despatch of a communication from the examining division (Time limit: M06)
16.04.2020Reply to a communication from the examining division
30.06.2020Communication of intention to grant the patent
03.02.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.03.2021Communication of intention to grant the patent
03.08.2021Application deemed to be withdrawn, date of legal effect  [2022/02]
24.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2022/02]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
03.02.2021Request for further processing filed
03.02.2021Full payment received (date of receipt of payment)
Request granted
16.02.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
16.04.2020Request for further processing filed
16.04.2020Full payment received (date of receipt of payment)
Request granted
28.04.2020Decision despatched
Fees paidRenewal fee
27.03.2018Renewal fee patent year 03
27.03.2019Renewal fee patent year 04
12.03.2020Renewal fee patent year 05
12.03.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2016096174  (INVIVOGEN [FR]) [E] 1-14* Claims, in particular compound CL632 in claim 2 and example 1.14 *
International search[Y]US2008286296  (EBENSEN THOMAS [DE], et al) [Y] 1-7, 8/1-7, 9/1-7 * ; paragraphs [0037]-[0041], [0048], [0050], [0101] *;
 [A]US7592326  (KARAOLIS DAVID K R [US]) [A] 1-7, 8/1-7, 9/1-7 * ; entire document *;
 [A]US7709458  (KARAOLIS DAVID K R [US], et al) [A] 1-7, 8/1-7, 9/1-7* ; entire document *;
 [Y]US2014205653  (DUBENSKY JR THOMAS W [US], et al) [Y] 1-7, 8/1-7, 9/1-7 * ; figure 1; paragraphs [0070], [0083] *
by applicantEP0296122
 US4978672
 US5637483
 US5698432
 WO9749395
 WO9835958
 US5811097
 WO9903854
 WO9920758
 US5904920
 WO9940196
 US5985290
 US6033674
 US6111090
 WO0103720
 US6277368
 WO0210192
 US6350445
 US6464973
 WO03037347
 WO03077914
 WO2004005281
 US6689607
 WO2004045532
 WO2004060319
 WO2004072051
 WO2005007190
 WO2005039549
 WO2005055808
 WO2005073224
 WO2005115451
 US7025962
 WO2006083289
 WO2006121168
 WO2006122806
 WO2007005874
 WO2007024945
 WO2007030377
 WO2007054279
 WO2007070514
 WO2007084786
 WO2007131201
 WO2007133822
 EP1866339
 EP0920505
 WO2008073687
 US7473761
 WO2009101611
 WO2009114335
 US7592326
 WO2009115562
 US7618632
 WO2009141386
 WO2010003118
 WO2010002655
 WO2010007120
 US2010028330
 WO2010019570
 WO2010027827
 WO2010026124
 WO2010029082
 US7709458
 WO2010060937
 US2010150946
 WO2010077634
 WO2010101849
 WO2010104833
 US7812135
 US2010310602
 WO2010149755
 US7867493
 WO2011025927
 WO2011028683
 WO2011051726
 US7943743
 WO2011066342
 US2011150892
 WO2011076786
 WO2011090754
 WO2011101409
 US8008449
 US8012469
 WO2011155607
 WO2012004367
 US2012039906
 WO2012022814
 US2012114649
 US8354509
 US8388967
 WO2013039954
 US8415355
 EP2581113
 WO2013079174
 EP1947183
 WO2013111105
 WO2013124826
 US8552156
 US8552002
 US8552003
 US8562997
 US8586023
 WO2013171639
 WO2013171640
 WO2013171641
 WO2013171642
 US8591886
 WO2013184757
 US8609089
 WO2014008218
 WO2014012479
 US2014044728
 US2014072566
 US8685980
 US8709424
 WO2014072493
 US8728476
 WO2014085318
 WO2014093936
 WO2014141104
 WO2014151616
 WO2014160160
 US8895705
 WO2014189805
 WO2015026684
 WO2015066188
 US2015210769
 US2015218274
 US2015259420
 WO2016096174
    - REED et al., Trends Immunol., (20090000), vol. 30, pages 23 - 32
    - DUBENSKYREED, Semin. Immunol., (20100000), vol. 22, pages 155 - 61
    - KASTENMULLER et al., J. Clin. Invest., (20110000), vol. 121, pages 1782 - 1796
    - COFFMAN et al., Immunity, (20100000), vol. 33, pages 492 - 503
    - YAN et al., Bioorg. Med. Chem Lett., (20080000), vol. 18, page 5631
    - SUN et al., Science, (20130000), vol. 339, no. 6121, pages 826 - 30
    - KRANZUSCH et al., Cell Reports, (20130000), vol. 3, pages 1362 - 68
    - JIN et al., Genes and Immunity, (20110000), vol. 12, pages 263 - 9
    - DINERGAO et al., Cell, (20130000), vol. 153, pages 748 - 762
    - CONLON, J. Immunol., (20130000), vol. 190, pages 5216 - 5225
    - JINYI et al., PLOS One, (20110000), vol. 8, page e77846
    - ZHANG et al., Mol. Cell., (20130000), vol. 51, pages 226 - 35
    - XIAOFITZGERALD, Mol. Cell, (20130000), vol. 51, pages 135 - 39
    - ISHIKAWA, H.BARBER, G.N., Nature, (20080000), vol. 455, pages 674 - 678
    - YI et al., PLos One, (20131021), vol. 8, no. 10, page e77846
    - IWASAKIMEDZHITOV, Science, (20100000), vol. 328, pages 1703 - 05
    - PANDEY, Cold Spring Harb Perspect Biol, (20150000), vol. 7, page a016246
    - EINSTEIN et al., Human Vaccines, (20090000), vol. 5, pages 705 - 19
    - AHMED et al., Nature Immunol., (20110000), vol. 12, pages 509 - 17
    - VANCE et al., Cell Host & Microbe, (20090000), vol. 6, pages 10 - 21
    - IRETONGALE, Viruses, (20110000), vol. 3, pages 906 - 19
    - CASKEY et al., J. Exp. Med., (20110000), vol. 208, pages 2357 - 77
    - BARBER, Immunol. Rev, (20110000), vol. 243, pages 99 - 108
    - ROMLING et al., Micrb. Mol. Biol. Rev., (20130000), vol. 77, pages 1 - 52
    - BURDETTE et al., Nature, (20110000), vol. 478, pages 515 - 18
    - BURDETTEVANCE, Nat Immunol., (20130000), vol. 14, pages 19 - 26
    - MCWHIRTER et al., J. Exp. Med., (20090000), vol. 206, pages 1899 - 1911
    - CRIMMINS et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 10191 - 10196
    - LEBER et al., PLoS Pathog, (20080000), vol. 4, no. 1, page e6
    - WITTE et al., mBio, (20120000), vol. 4, pages e00282 - 13
    - SAUER et al., Infect. Immun., (20110000), vol. 79, pages 688 - 94
    - DAVIES et al., Cell, (20120000), vol. 149, pages 358 - 70
    - DINERGAOABLASSER et al., Nature, (20130000), vol. 498, pages 380 - 84
    - XIAOFITZGERALD, Mol. Cell, vol. 51, pages 135 - 39
    - WILSON, J. Immunol. Methods, (19940000), vol. 175, pages 267 - 273
    - YARMUSH, J. Biochem. Biophys. Methods, (19920000), vol. 25, pages 85 - 97
    - WARD et al., Nature, (19890000), vol. 341, pages 544 - 546
    - VAN ERP et al., J. Immunoassay, (19910000), vol. 12, pages 425 - 43
    - NELSONGRISWOLD, Comput. Methods Programs Biomed., (19880000), vol. 27, pages 65 - 8
    - MCCUNE et al., Cancer, (19790000), vol. 43, page 1619
    - CHEMICAL ABSTRACTS, Database accession no. 946414-94-4
    - HAMID, O. et al., New England Journal of Medicine, (20130000), vol. 369, no. 2, pages 134 - 44
    - YAMAZAKI et al., The Journal of Immunology, (19990000), vol. 163, pages 5178 - 5182
    - Crit. Rev. Ther. Drug Carrier Syst., (20040000), vol. 21, pages 387 - 422
    - Nanomedicine: Nanotechnology, Biology and Medicine, (20050000), vol. 1, pages 22 - 30
    - STRBO et al., Immunol Res., (20131200), vol. 57, no. 1-3, pages 31 1 - 25
    - DESSUREAULT et al., Ann. Surg. Oncol., (20070000), vol. 14, pages 869 - 84
    - EAGERNEMUNAITIS, Mol. Ther., (20050000), vol. 12, pages 18 - 27
    - Remington's Pharmaceutical Sciences, American Pharmaceutical Association, (19750000), pages 1405 - 1412,1461-1487
    - C. AMMANP. MEIERA. E. MERBACH, J. Magn. Reson., (19820000), vol. 46, pages 319 - 321
    - ZHAO et al., Nucleosides, Nucleotides, and Nucleic Acid, (20090000), vol. 289, pages 352 - 378
    - YI et al., PLoS One, (20130000), vol. 8, no. 10, page e77846
    - BUTT et al., Protein expression and purification, (20050000), pages 1 - 9
    - ASLANIDIS et al., Nucleic acids research, 18.20, (19900000), pages 6069 - 6074
    - NIESEN et al., Nature protocols 2.9, (20070000), pages 2212 - 2221
    - FITZGERALD et al., Nature Immunology,, (20030000), vol. 4, no. 5, pages 491 - 496
otherWO2016096174
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.